GlaxoSmithKline and Novartis responded to an Indian parliamentary report suggesting that some drugs have been approved in the country without mandatory Phase III trials being conducted as required or seeking expert opinions. The report also alleged that there had been collusion among drugmakers, experts and officials from the Central Drugs Standard Control Organisation (CDSCO)
The report added that in the case of everolimus, the CDSCO relied on the judgment of non-medical staff rather than seeking the opinion of independent experts
http://www.firstwordpharma.com/node/981929
No comments:
Post a Comment